CD79A and nasopharyngeal carcinoma: To date, serological detection of EBV-related antibodies including VCA-IgA, EA-IgA, and EBV nuclear antigen 1 (EBNA1)-IgA antibodies has been widely applied in NPC screening programs (Zeng et al., 1982; Liu et al., 2012; Coghill et al., 2014; Gao et al., 2017).